X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (11) 11
female (9) 9
male (9) 9
bevacizumab (8) 8
care and treatment (8) 8
middle aged (8) 8
oncology (8) 8
chemotherapy (7) 7
history (7) 7
survival (7) 7
temozolomide (7) 7
aged (6) 6
biography (6) 6
glioblastoma multiforme (6) 6
patients (6) 6
analysis (5) 5
brain neoplasms - drug therapy (5) 5
glioblastoma (5) 5
hematology (5) 5
medicine & public health (5) 5
radiotherapy (5) 5
adult (4) 4
cancer (4) 4
glioblastoma - drug therapy (4) 4
internal medicine (4) 4
lomustine (4) 4
magnetic resonance imaging (4) 4
neurology (4) 4
prognosis (4) 4
retrospective studies (4) 4
1813-1883 (3) 3
abridged index medicus (3) 3
acteurs de cinéma (3) 3
biographies (3) 3
brain cancer (3) 3
cancer research (3) 3
combination (3) 3
composers (3) 3
disease-free survival (3) 3
geschichte (3) 3
irinotecan (3) 3
medical prognosis (3) 3
motion picture actors and actresses (3) 3
motion picture actors and actresses biography (3) 3
motivation (3) 3
neoplasm recurrence, local - drug therapy (3) 3
phase-ii trial (3) 3
plus irinotecan (3) 3
radiation therapy (3) 3
recurrent glioblastoma (3) 3
studies (3) 3
treatment outcome (3) 3
wagner, richard (3) 3
wagner, richard, 1813-1883 (3) 3
1837-1930 (2) 2
actrices de cinéma (2) 2
analysis of variance (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bevacizumab - therapeutic use (2) 2
bibliographies (2) 2
bibliography (2) 2
bilirubin (2) 2
biografie (2) 2
biographie (2) 2
brain neoplasms - mortality (2) 2
brain neoplasms - pathology (2) 2
brain tumors (2) 2
camptothecin - analogs & derivatives (2) 2
cardiomyopathy (2) 2
children (2) 2
clinical outcomes (2) 2
clinical trials (2) 2
cognition (2) 2
cohort studies (2) 2
composers biography (2) 2
composers biography. germany (2) 2
composers' spouses (2) 2
correspondence, reminiscences, etc. (2) 2
diabetes (2) 2
diabetes mellitus, type 2 - complications (2) 2
diaries (2) 2
dictionaries (2) 2
disease progression (2) 2
dna methylation (2) 2
dosage and administration (2) 2
drug therapy (2) 2
drug therapy, combination (2) 2
efficacy (2) 2
electronic books (2) 2
fibrosis (2) 2
filmkunst (2) 2
filmschauspieler (2) 2
follow-up studies (2) 2
germany (2) 2
glioblastoma - pathology (2) 2
glioma (2) 2
health (2) 2
heart diseases (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Stacks (2) 2
Music - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Media Commons - Storage (1) 1
Music - Reference (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University E.J. Pratt - Storage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10172, pp. 678 - 688
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2017, Volume 66, Issue 2, pp. 518 - 527
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 7/2016, Volume 142, Issue 7, pp. 1581 - 1589
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0124606
Cyclophilins are a group of highly conserved cytosolic enzymes that have a peptidylprolyl cis/trans isomerase activity. Cyclophilin A (CyPA) can be secreted in... 
FIBROSIS | VITRO | EMMPRIN CD147 | OXIDATIVE STRESS | CYCLOSPORINE-A | VIRUS | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | Tumor Necrosis Factor-alpha - metabolism | Autoimmune Diseases - physiopathology | Inflammation - pathology | Humans | Myocarditis - drug therapy | Cyclosporins - pharmacology | Inflammation - complications | Matrix Metalloproteinase 9 - metabolism | Cyclosporins - therapeutic use | T-Lymphocytes - drug effects | Monocytes - pathology | Autoimmune Diseases - pathology | Interleukin-6 - metabolism | Autoimmune Diseases - drug therapy | Disease Models, Animal | Cyclophilin A - metabolism | Myocarditis - complications | Autoimmune Diseases - complications | Myocardium - pathology | Cell Adhesion - drug effects | Monocytes - drug effects | Cell Movement - drug effects | Cyclophilin A - antagonists & inhibitors | Animals | Troponin I | Fibrosis | Extracellular Space - chemistry | Macrophages - drug effects | Mice | Myocarditis - pathology | Myocarditis - physiopathology | Ventricular Remodeling - drug effects | Myocarditis | Models | Inflammation | Prognosis | T cells | Leukocyte migration | Cardiomyopathy | Neuropathology | Lymphocytes T | Macrophages | Interleukin 6 | Reduction | Ischemia | Calcium-binding protein | Inhibition | Heart diseases | Injury analysis | Heart failure | Pathogens | Peptidylprolyl isomerase | Immunization | Internal medicine | Cytokines | Pharmacology | Tumor necrosis factor-α | Gelatinase B | Medicine | Studies | Pathology | Monocytes | Troponin | Injury prevention | Inhibitors | Cell death
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 8/2016, Volume 129, Issue 1, pp. 93 - 100
Journal Article
Oncology, ISSN 0030-2414, 10/2013, Volume 85, Issue 3, pp. 191 - 195
Journal Article
Experimental hematology & oncology, ISSN 2162-3619, 12/2012, Volume 1, Issue 1, p. 37
Intravascular diffuse large B-cell lymphoma limited to the CNS (cIVL) is a very rare malignant disorder characterized by a selective accumulation of neoplastic... 
Care and treatment | Anthracyclines | Chemotherapy | Magnetic resonance imaging | Brain tumors | Lymphomas | Dosage and administration | B cells | Methotrexate | Cancer | Neurophysiology | Intravascular CNS lymphoma | Angioendotheliomatosis | Intravascular lymphoma | Angiotropic lymphoma | High-dose methotrexate-based polychemotherapy
Journal Article
by Ferrie, J and Shipley, M and Cappuccio, F and Brunner, E and Miller, M and Kumari, M and Marmot, M and Coenen, A and Castillo, J L and Araya, F and Bustamante, G and Montecino, L and Torres, C and Oporto, S and Gronli, J and Fiske, E and Murison, R and Bjorvatn, B and Sorensen, E and Ursin, R and Portas, C M and Rajaraman, S and Gribok, A and Wesensten, N and Balkin, T and Reifman, J and Dursunoglu, N and Ozkurt, S and Baser, S and Delen, O and Sarikaya, S and Sadler, P and Mitchell, P and Françon, D and Decobert, M and Herve, B and Richard, A and Griebel, G and Avenet, P and Scatton, B and Fur, G L and Eckert, D and Jordan, A and Wellman, A and Smith, S and Malhotra, A and White, D and Bruck, D and Thomas, I and Kritikos, A and Oertel, W and Stiasny-Kolster, K and Garcia-Borreguero, D and Poewe, W and Hoegl, B and Kohnen, R and Schollmayer, E and Keffel, J and Trenkwalder, C and Valle, A and Roizenblatt, S and Fregni, F and Boggio, P and Tufik, S and Ward, K and Robertson, L and Palmer, L and Eastwood, P and Hillman, D and Lee, J and Mukherjee, S and de Padova, V and Barbato, G and Ficca, G and Zilli, I and Salzarulo, P and Veldi, M and Hion, T and Vasar, V and Kull, M and Nowak, L and Davis, J and Latzer, Y and Tzischinsky, O and Crowley, S and Carskadon, M and Anca-Herschkovitsch, M and Frey, D and Ortega, J and Wiseman, C and Farley, C and Wright, K and Campbell, A and Neill, A and Spiegel, K and Leproult, R and Tasali, E and Scherberg, N and van Cauter, E and Noradina, A T and ...
Sleep and Biological Rhythms, ISSN 1446-9235, 8/2007, Volume 5, Issue S1, pp. A1 - A189
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article